Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$1.4 - $2.09 $2,739 - $4,090
-1,957 Reduced 1.72%
111,937 $201,000
Q3 2023

Nov 14, 2023

SELL
$1.6 - $2.78 $4,054 - $7,044
-2,534 Reduced 2.18%
113,894 $226,000
Q2 2023

Aug 11, 2023

BUY
$2.46 - $4.07 $62,437 - $103,300
25,381 Added 27.88%
116,428 $298,000
Q1 2023

May 15, 2023

BUY
$1.38 - $6.0 $125,644 - $546,282
91,047 New
91,047 $365,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.